Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
10/08/2026 22:58
Oramed Pharmaceuticals Inc <ORMP.OQ> expected to post earnings of 43 cents a share - Earnings Preview
Oramed Pharmaceuticals Inc ORMP.OQ ORMP.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Oramed Pharmaceuticals Inc is for earnings of 43 cents per share.
Wall Street's median 12-month price target for Oramed Pharmaceuticals Inc is $6.25, about 45.3% above its last closing price of $4.30
This summary was machine generated August 10 at 21:58 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results